Lung cancer (LC) has become the leading cancer-related cause of death in the US and in developed European countries in the last decade. Its incidence is still growing in females and in smokers. Surgery remains the treatment of choice whenever feasible, but unfortunately, many patients have an advanced LC at presentation and one-third of potentially operable patients do not receive a tumor resection because of their low compliance for intervention due to their compromised cardiopulmonary functions and other comorbidities. For these patients the alternative therapeutic options are stereotactic radiotherapy or percutaneous radiofrequency. When surgery is planned, an anatomical resection (segmentectomy, lobectomy, bilobectomy, pneumonectomy, sleeve lobectomy) is usually performed; wedge resection (considered as a nonanatomical one) is generally the accepted option for unfit patients. The recent increase in discovering small and peripheral LCs and/or ground-glass opacities with screening programs has dramatically increased surgeons' interest in limited resections. The role of these resections is discussed. Also, recent improvements in molecular biology techniques have increased the chemotherapic options for neoadjuvant LC treatment. The role and the importance of targeted chemotherapy is also discussed.

Emerging treatment options in the management of non-small cell lung cancer / Filosso, Pier Luigi; Sandri, A; Oliaro, Alberto; Filippi, Andrea Riccardo; Cassinis, Maria Carla; Ricardi, Umberto; Lausi, Paolo Olivo; Asioli, Sofia; Ruffini, Enrico. - In: LUNG CANCER: TARGETS AND THERAPY. - ISSN 1179-2728. - 2:(2011), pp. 11-28. [10.2147/LCTT.S8618]

Emerging treatment options in the management of non-small cell lung cancer

FILOSSO, Pier Luigi;
2011-01-01

Abstract

Lung cancer (LC) has become the leading cancer-related cause of death in the US and in developed European countries in the last decade. Its incidence is still growing in females and in smokers. Surgery remains the treatment of choice whenever feasible, but unfortunately, many patients have an advanced LC at presentation and one-third of potentially operable patients do not receive a tumor resection because of their low compliance for intervention due to their compromised cardiopulmonary functions and other comorbidities. For these patients the alternative therapeutic options are stereotactic radiotherapy or percutaneous radiofrequency. When surgery is planned, an anatomical resection (segmentectomy, lobectomy, bilobectomy, pneumonectomy, sleeve lobectomy) is usually performed; wedge resection (considered as a nonanatomical one) is generally the accepted option for unfit patients. The recent increase in discovering small and peripheral LCs and/or ground-glass opacities with screening programs has dramatically increased surgeons' interest in limited resections. The role of these resections is discussed. Also, recent improvements in molecular biology techniques have increased the chemotherapic options for neoadjuvant LC treatment. The role and the importance of targeted chemotherapy is also discussed.
2
11
28
Emerging treatment options in the management of non-small cell lung cancer / Filosso, Pier Luigi; Sandri, A; Oliaro, Alberto; Filippi, Andrea Riccardo; Cassinis, Maria Carla; Ricardi, Umberto; Lausi, Paolo Olivo; Asioli, Sofia; Ruffini, Enrico. - In: LUNG CANCER: TARGETS AND THERAPY. - ISSN 1179-2728. - 2:(2011), pp. 11-28. [10.2147/LCTT.S8618]
Filosso, Pier Luigi; Sandri, A; Oliaro, Alberto; Filippi, Andrea Riccardo; Cassinis, Maria Carla; Ricardi, Umberto; Lausi, Paolo Olivo; Asioli, Sofia; Ruffini, Enrico
File in questo prodotto:
File Dimensione Formato  
562873.pdf

Accesso riservato

Dimensione 1.36 MB
Formato Adobe PDF
1.36 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1294956
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact